| Literature DB >> 35273810 |
Eiji Matsusue1, Chie Inoue1, Sadaharu Tabuchi2, Hiroki Yoshioka2, Yuichiro Nagao2, Kensuke Matsumoto1, Kazuhiko Nakamura1, Shinya Fujii3.
Abstract
On conventional magnetic resonance imaging (MRI), hemangioblastomas typically appear as mural nodules with an adjacent surrounding cyst or a solid mass in the cerebellum. However, hemangioblastomas sometimes cannot be reliably distinguished using this imaging technique from other tumors, especially pilocytic astrocytomas and metastatic tumors, because of their similar imaging findings and locations. Herein, we report three cases of cerebellar hemangioblastomas and review their findings on conventional and advanced MRI, including diffusion-weighted imaging (DWI), dynamic susceptibility-weighted contrast-enhanced perfusion-weighted imaging (DSC-PWI), and magnetic resonance spectroscopy (MRS). Solid contrast-enhanced lesions of hemangioblastomas showed increased apparent diffusion coefficient values on DWI, increased relative cerebral blood volume ratio on DSC-PWI, and high lipid/lactate peak on MRS. Therefore, advanced MRI techniques can be helpful in understanding the pathological and metabolic changes of hemangioblastomas and may be useful for their characterization.Entities:
Keywords: DWI; Hemangioblastoma; MRS; PWI; magnetic resonance imaging
Year: 2022 PMID: 35273810 PMCID: PMC8902200 DOI: 10.1177/20584601221077074
Source DB: PubMed Journal: Acta Radiol Open
Figure 1.Representative magnetic resonance imaging findings of a 35-year-old woman with hemangioblastoma (Case 1). (a) Axial T1-weighted image (T1WI) showing a cystic mass lesion with a mural nodule in the left cerebellar hemisphere. The cystic lesion is low-intense, while the nodule (arrow) is slightly low-intense compared to the cerebellum. (b) Axial T2WI showing flow voids (arrow) in the mural nodule. (c) Axial contrast-enhanced T1WI showing homogeneous enhancement of the mural nodule (arrow) and no enhancement of the cyst wall. (d) Axial diffusion-weighted image showing that the mural nodule (arrow) is low-intense. (e) A corresponding apparent diffusion coefficient (ADC) map showing increased ADC of the nodule (arrow). The ADC value is 1.6 × 10−3 mm2/s. (f) Relative cerebral blood volume (rCBV) map showing increased relative CBV (rCBV) of the nodule. The rCBV ratio, defined as the maximal rCBV (enhanced lesion in yellow circle)/rCBV (contralateral normal white matter in red circle), is 12.42. (g) The intensity–time curve showing only a partial return to the baseline level (yellow line) due to massive leakage of contrast media into the interstitial space.
Figure 2.Representative magnetic resonance imaging and magnetic resonance spectroscopy findings of a 32-year-old woman with hemangioblastoma (Case 2). (a) Axial T1-weighted image (T1WI) showing a low-intensity edematous lesion in the left cerebellar hemisphere. The nodular lesion (arrow) is unclear. (b) Axial T2WI showing a slight high-intensity nodule (arrow) with perifocal edema. (c) Axial contrast-enhanced T1WI (CE-T1WI) showing homogeneous enhancement of the nodule (arrow). (d) Axial diffusion-weighted image showing that the nodule is unclear (arrow). (e) A corresponding apparent diffusion coefficient (ADC) map showing slightly increased ADC of the nodule (arrow). The ADC value is 1.3 × 10−3 mm2/s. (f) Relative cerebral blood volume (rCBV) map showing increased rCBV. (g) The volume of interest (VOI) for magnetic resonance spectroscopy with short echo time (36 ms) in axial CE-T1WI (square). The VOI includes the edematous cerebellar region around the cerebellar tumor nodule. The VOI measures 16 × 25 × 21 mm. (h) The spectra showing slightly increased lipid and/or lactate peak. Other spectra, including choline, n-acetylaspartate, and creatine peaks, are almost normal.
Figure 3.Representative magnetic resonance imaging and magnetic resonance spectroscopy findings of an 84-year-old man with hemangioblastoma (Case 3). (a) Axial T1-weighted image (T1WI) showing a homogenous low-intense mass lesion (arrow) in the left cerebellar hemisphere. (b) Axial T2WI showing flow voids (arrow) in the mass lesion with perifocal edema. (c) Axial contrast-enhanced T1WI (CE-T1WI) showing homogeneous enhancement of the mass lesion (arrow). (d) Axial diffusion-weighted image (DWI) showing the low-intensity mass lesion (arrow). (e) A corresponding apparent diffusion coefficient (ADC) map showing increased ADC of the nodule. The ADC value of the circle is 2.3 × 10−3 mm2/s. (f) Relative cerebral blood volume (rCBV) map showing increased CBV. The rCBV ratio, defined as the maximal rCBV (enhanced lesion—yellow circle)/rCBV (contralateral normal white matter—red circle) is 12.27. (g) The intensity–time curve showing only a partial return (yellow line) to the baseline level due to massive leakage of contrast media into the interstitial space. (h) The volume of interest (VOI) for magnetic resonance spectroscopy with short echo time (36 ms) in the axial CE-T1WI (square). The VOI includes the entire enhanced lesion without necrosis. The VOI measures 16 × 20 × 15 mm. (i) The spectra showing prominent lipid and/or lactate peaks. Other spectra, including choline, n-acetylaspartate, and creatine peaks, are almost absent.
Summary of the clinical data and MRI and MRS findings for cerebellar hemangioblastomas.
| Case | Age/sex | Clinical presentation | Ope | VHL findings | IH | Conventional MRI findings | ADC map/ADC value (10−3 mm2/s) | rCBV map/rCBV ratio | Lip-lac | Cho NAACr |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 35/F | ・Headache | TR | Negative | Inhibin-α D2-40 | Cyst with nodule with FV | Increased/1.6 | Increased/12.42 | NA | NA |
| NA | ||||||||||
| NA | ||||||||||
| 2 | 32/F | ・Headache | TR | Negative | Inhibin-α S100 | Solid nodule without FV | Increased/1.3 | Increased/NA | + | + |
| ・Dizziness | + | |||||||||
| ・Sensory disorders | + | |||||||||
| 3 | 84/M | ・Dysarthria | TR | Negative | Inhibin-α S100 | Solid mass with FV | Increased/2.3 | Increased/12.27 | ++ |
|
| ・Lightheadedness |
| |||||||||
|
|
MRI: magnetic resonance imaging; MRS: magnetic resonance spectroscopy; Ope: operation; VHL: Von Hippel–Lindau disease; IH: positive immunohistochemistry tests for stromal cells; ADC: apparent diffusion coefficiency; rCBV: relative cerebral volume; Lip-Lac: lipid and/or lactate; Cho: choline; NAA: N-acetylaspartate; Cr: creatine; FV: flow void; TR: total resection; NA: not available; +: present; ++: elevated; –: absent.
Comparisons of general imaging features of hemangioblastomas, pilocytic astrocytomas, and metastatic tumors on conventional and advanced MRI.
| Hemangioblastomas | Pilocytic astrocytomas | Metastatic tumors | |
|---|---|---|---|
| Age | Adults | Children | Adults |
| Morphology | Cyst with a mural nodule, solid, cyst, solid and cyst | Cyst with a mural nodule, Solid | Solid with necrosis |
| Number | Single | Single | Multiple > single |
| Flow voids |
|
|
|
| rCBV | Prominent increased | Mild increased | Mild to prominent increased |
| ADC | Increased | Iso to increased | Decreased to mild increased |
| Lip/Lac | |||
| Cho |
|
| |
| NAA |
|
|
|
MRI: magnetic resonance imaging; rCBV: cerebral blood volume; ADC: apparent diffusion coefficiency; Lip/Lac: lipid and/or lactate; +: present; Cho: choline; −: absent; ++: elevated; NAA: N-acetylaspartate.